array:24 [
  "pii" => "S1578219020300147"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2019.11.005"
  "estado" => "S300"
  "fechaPublicacion" => "2020-03-01"
  "aid" => "2275"
  "copyright" => "AEDV"
  "copyrightAnyo" => "2019"
  "documento" => "simple-article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "cor"
  "cita" => "Actas Dermosifiliogr. 2020;111:87"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:20 [
      "pii" => "S0001731019303771"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2019.11.001"
      "estado" => "S300"
      "fechaPublicacion" => "2020-03-01"
      "aid" => "2275"
      "copyright" => "AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "cor"
      "cita" => "Actas Dermosifiliogr. 2020;111:87"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 37
        "formatos" => array:2 [
          "HTML" => 19
          "PDF" => 18
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Comentario editorial</span>"
        "titulo" => "Apremilast en psoriasis"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:1 [
            "paginaInicial" => "87"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Apremilast in Psoriasis"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "A&#46; P&#233;rez Ferriols"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "P&#233;rez Ferriols"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219020300147"
          "doi" => "10.1016/j.adengl.2019.11.005"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020300147?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019303771?idApp=UINPBA000044"
      "url" => "/00017310/0000011100000002/v2_202009190635/S0001731019303771/v2_202009190635/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:20 [
    "pii" => "S1578219020300135"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2019.03.029"
    "estado" => "S300"
    "fechaPublicacion" => "2020-03-01"
    "aid" => "2193"
    "copyright" => "AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "cor"
    "cita" => "Actas Dermosifiliogr. 2020;111:87-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>"
      "titulo" => "Early Syphilis&#58; New Diagnostic Approaches in a Changing Scenario"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "87"
          "paginaFinal" => "88"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "S&#237;filis precoz&#58; nuevas aproximaciones diagn&#243;sticas para un escenario cambiante"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "T&#46; Toledo Pastrana"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "T&#46;"
              "apellidos" => "Toledo Pastrana"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731019301279"
        "doi" => "10.1016/j.ad.2019.03.002"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019301279?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020300135?idApp=UINPBA000044"
    "url" => "/15782190/0000011100000002/v1_202004140647/S1578219020300135/v1_202004140647/en/main.assets"
  ]
  "en" => array:12 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>"
    "titulo" => "Apremilast in Psoriasis"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "87"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "A&#46; P&#233;rez Ferriols"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "A&#46;"
            "apellidos" => "P&#233;rez Ferriols"
            "email" => array:1 [
              0 => "perez_ampferr@gva.es"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital General Universitario&#44; Valencia&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Apremilast en psoriasis"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The authors present the results of a Delphi study conducted in Spain on the use of apremilast in psoriasis&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Apremilast is a &#8220;small-molecule&#8221; oral phosphodiesterase 4 inhibitor that according to its summary of product characteristics is indicated for the treatment of psoriatic arthritis and chronic moderate to severe plaque psoriasis&#46; The position of apremilast in the current arsenal of treatments for psoriasis has been influenced by several factors&#46; First&#44; its limited effectiveness compared with other alternatives&#59; second its adverse effects&#44; which in many cases require withdrawal of treatment due to poor tolerability&#59; and last but not least&#44; its cost&#44; which is similar to that of the most effective biologic drugs available and higher than that of other biosimilars&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">The authors&#44; all experts in psoriasis&#44; chose 5 points of interest to analyze using a Delphi questionnaire&#46; After reviewing each point based on the existing literature&#44; the panel concluded that apremilast might be a treatment option for patients with a different profile to that studied in the clinical trials&#46; They highlight the need for a consensus-based definition of moderate psoriasis&#44; which is where apremilast could possibly be positioned as a treatment option preceding biologic therapy&#46; Finally&#44; they stress the need for more scientific evidence from clinical trials and real-world studies to verify the opinions expressed in this study&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; P&#233;rez Ferriols A&#46; Apremilast en psoriasis&#46; Actas Dermosifiliogr&#46; 2020&#59;111&#58;87&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Reference"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:1 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Estudio Delphi para el uso de apremilast en psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "J&#46;M&#46; Carrascosa"
                            1 => "I&#46; Belinch&#243;n"
                            2 => "R&#46; Rivera"
                            3 => "M&#46; Ara"
                            4 => "M&#46; Bustinduy"
                            5 => "P&#46; Herranz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Actas Dermosifilogr"
                        "fecha" => "2020"
                        "volumen" => "111"
                        "paginaInicial" => "115"
                        "paginaFinal" => "134"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000011100000002/v1_202004140647/S1578219020300147/v1_202004140647/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "66476"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Commentaries"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011100000002/v1_202004140647/S1578219020300147/v1_202004140647/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020300147?idApp=UINPBA000044"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

Commentaries
Apremilast in Psoriasis
Apremilast en psoriasis
A. Pérez Ferriols
Servicio de Dermatología, Hospital General Universitario, Valencia, Spain
Leído
3504
Veces
se ha leído el artículo
1528
Total PDF
1976
Total HTML
Compartir estadísticas
 array:24 [
  "pii" => "S1578219020300147"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2019.11.005"
  "estado" => "S300"
  "fechaPublicacion" => "2020-03-01"
  "aid" => "2275"
  "copyright" => "AEDV"
  "copyrightAnyo" => "2019"
  "documento" => "simple-article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "cor"
  "cita" => "Actas Dermosifiliogr. 2020;111:87"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "es" => array:20 [
      "pii" => "S0001731019303771"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2019.11.001"
      "estado" => "S300"
      "fechaPublicacion" => "2020-03-01"
      "aid" => "2275"
      "copyright" => "AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "cor"
      "cita" => "Actas Dermosifiliogr. 2020;111:87"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 37
        "formatos" => array:2 [
          "HTML" => 19
          "PDF" => 18
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Comentario editorial</span>"
        "titulo" => "Apremilast en psoriasis"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:1 [
            "paginaInicial" => "87"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Apremilast in Psoriasis"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "A&#46; P&#233;rez Ferriols"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "P&#233;rez Ferriols"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219020300147"
          "doi" => "10.1016/j.adengl.2019.11.005"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020300147?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019303771?idApp=UINPBA000044"
      "url" => "/00017310/0000011100000002/v2_202009190635/S0001731019303771/v2_202009190635/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:20 [
    "pii" => "S1578219020300135"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2019.03.029"
    "estado" => "S300"
    "fechaPublicacion" => "2020-03-01"
    "aid" => "2193"
    "copyright" => "AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "cor"
    "cita" => "Actas Dermosifiliogr. 2020;111:87-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>"
      "titulo" => "Early Syphilis&#58; New Diagnostic Approaches in a Changing Scenario"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "87"
          "paginaFinal" => "88"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "S&#237;filis precoz&#58; nuevas aproximaciones diagn&#243;sticas para un escenario cambiante"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "T&#46; Toledo Pastrana"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "T&#46;"
              "apellidos" => "Toledo Pastrana"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731019301279"
        "doi" => "10.1016/j.ad.2019.03.002"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019301279?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020300135?idApp=UINPBA000044"
    "url" => "/15782190/0000011100000002/v1_202004140647/S1578219020300135/v1_202004140647/en/main.assets"
  ]
  "en" => array:12 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>"
    "titulo" => "Apremilast in Psoriasis"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "87"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "A&#46; P&#233;rez Ferriols"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "A&#46;"
            "apellidos" => "P&#233;rez Ferriols"
            "email" => array:1 [
              0 => "perez_ampferr@gva.es"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital General Universitario&#44; Valencia&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Apremilast en psoriasis"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The authors present the results of a Delphi study conducted in Spain on the use of apremilast in psoriasis&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Apremilast is a &#8220;small-molecule&#8221; oral phosphodiesterase 4 inhibitor that according to its summary of product characteristics is indicated for the treatment of psoriatic arthritis and chronic moderate to severe plaque psoriasis&#46; The position of apremilast in the current arsenal of treatments for psoriasis has been influenced by several factors&#46; First&#44; its limited effectiveness compared with other alternatives&#59; second its adverse effects&#44; which in many cases require withdrawal of treatment due to poor tolerability&#59; and last but not least&#44; its cost&#44; which is similar to that of the most effective biologic drugs available and higher than that of other biosimilars&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">The authors&#44; all experts in psoriasis&#44; chose 5 points of interest to analyze using a Delphi questionnaire&#46; After reviewing each point based on the existing literature&#44; the panel concluded that apremilast might be a treatment option for patients with a different profile to that studied in the clinical trials&#46; They highlight the need for a consensus-based definition of moderate psoriasis&#44; which is where apremilast could possibly be positioned as a treatment option preceding biologic therapy&#46; Finally&#44; they stress the need for more scientific evidence from clinical trials and real-world studies to verify the opinions expressed in this study&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; P&#233;rez Ferriols A&#46; Apremilast en psoriasis&#46; Actas Dermosifiliogr&#46; 2020&#59;111&#58;87&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Reference"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:1 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Estudio Delphi para el uso de apremilast en psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "J&#46;M&#46; Carrascosa"
                            1 => "I&#46; Belinch&#243;n"
                            2 => "R&#46; Rivera"
                            3 => "M&#46; Ara"
                            4 => "M&#46; Bustinduy"
                            5 => "P&#46; Herranz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Actas Dermosifilogr"
                        "fecha" => "2020"
                        "volumen" => "111"
                        "paginaInicial" => "115"
                        "paginaFinal" => "134"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000011100000002/v1_202004140647/S1578219020300147/v1_202004140647/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "66476"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Commentaries"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011100000002/v1_202004140647/S1578219020300147/v1_202004140647/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219020300147?idApp=UINPBA000044"
]
Información del artículo
ISSN: 15782190
Idioma original: Inglés
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 8 11 19
2024 Octubre 53 52 105
2024 Septiembre 53 22 75
2024 Agosto 82 57 139
2024 Julio 49 34 83
2024 Junio 56 21 77
2024 Mayo 66 22 88
2024 Abril 61 26 87
2024 Marzo 57 28 85
2024 Febrero 47 25 72
2024 Enero 53 33 86
2023 Diciembre 40 14 54
2023 Noviembre 61 29 90
2023 Octubre 45 12 57
2023 Septiembre 34 35 69
2023 Agosto 33 9 42
2023 Julio 31 30 61
2023 Junio 40 25 65
2023 Mayo 35 20 55
2023 Abril 25 20 45
2023 Marzo 30 28 58
2023 Febrero 38 22 60
2023 Enero 22 25 47
2022 Diciembre 37 41 78
2022 Noviembre 20 29 49
2022 Octubre 25 15 40
2022 Septiembre 21 50 71
2022 Agosto 26 32 58
2022 Julio 28 38 66
2022 Junio 19 29 48
2022 Mayo 26 31 57
2022 Abril 31 24 55
2022 Marzo 27 40 67
2022 Febrero 23 21 44
2022 Enero 20 26 46
2021 Diciembre 24 56 80
2021 Noviembre 24 34 58
2021 Octubre 43 52 95
2021 Septiembre 18 36 54
2021 Agosto 19 28 47
2021 Julio 21 20 41
2021 Junio 21 22 43
2021 Mayo 37 44 81
2021 Abril 71 44 115
2021 Marzo 36 28 64
2021 Febrero 31 21 52
2021 Enero 29 16 45
2020 Diciembre 27 19 46
2020 Noviembre 19 10 29
2020 Octubre 15 7 22
2020 Septiembre 30 14 44
2020 Agosto 28 14 42
2020 Julio 11 7 18
2020 Junio 18 22 40
2020 Mayo 42 18 60
2020 Abril 76 26 102
2020 Marzo 10 12 22
2020 Febrero 4 2 6
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?